115 related articles for article (PubMed ID: 16563234)
21. Antiglioma effects of a new, low molecular mass, inhibitor of fibroblast growth factor.
Cuevas P; Carceller F; Angulo J; González-Corrochano R; Cuevas-Bourdier A; Giménez-Gallego G
Neurosci Lett; 2011 Mar; 491(1):1-7. PubMed ID: 21193016
[TBL] [Abstract][Full Text] [Related]
22. Preferential neurotrophic activity of fibroblast growth factor-20 for dopaminergic neurons through fibroblast growth factor receptor-1c.
Ohmachi S; Mikami T; Konishi M; Miyake A; Itoh N
J Neurosci Res; 2003 May; 72(4):436-43. PubMed ID: 12704805
[TBL] [Abstract][Full Text] [Related]
23. Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin.
Martín V; Herrera F; Carrera-Gonzalez P; García-Santos G; Antolín I; Rodriguez-Blanco J; Rodriguez C
Cancer Res; 2006 Jan; 66(2):1081-8. PubMed ID: 16424044
[TBL] [Abstract][Full Text] [Related]
24. Basic fibroblast growth factor promotes glial cell-derived neurotrophic factor gene expression mediated by activation of ERK5 in rat C6 glioma cells.
Obara Y; Nemoto W; Kohno S; Murata T; Kaneda N; Nakahata N
Cell Signal; 2011 Apr; 23(4):666-72. PubMed ID: 21130871
[TBL] [Abstract][Full Text] [Related]
25. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
Li B; Chang CM; Yuan M; McKenna WG; Shu HK
Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
[TBL] [Abstract][Full Text] [Related]
26. Treatment of basal cell carcinoma with dobesilate.
Cuevas P; Arrazola JM
J Am Acad Dermatol; 2005 Sep; 53(3):526-7. PubMed ID: 16112368
[No Abstract] [Full Text] [Related]
27. β-Elemene inhibits proliferation through crosstalk between glia maturation factor β and extracellular signal‑regulated kinase 1/2 and impairs drug resistance to temozolomide in glioblastoma cells.
Zhu TZ; Li XM; Luo LH; Xu YH; Cao P; Liu Y; Liang GB
Mol Med Rep; 2014 Aug; 10(2):1122-8. PubMed ID: 24866280
[TBL] [Abstract][Full Text] [Related]
28. Signaling pathways involved in antioxidant control of glioma cell proliferation.
Martín V; Herrera F; García-Santos G; Antolín I; Rodriguez-Blanco J; Rodriguez C
Free Radic Biol Med; 2007 Jun; 42(11):1715-22. PubMed ID: 17462539
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factor-2 up-regulates the expression of nestin through the Ras-Raf-ERK-Sp1 signaling axis in C6 glioma cells.
Chang KW; Huang YL; Wong ZR; Su PH; Huang BM; Ju TK; Yang HY
Biochem Biophys Res Commun; 2013 May; 434(4):854-60. PubMed ID: 23611784
[TBL] [Abstract][Full Text] [Related]
30. Autocrine signaling through Ras regulates cell survival activity in human glioma cells: potential cross-talk between Ras and the phosphatidylinositol 3-kinase-Akt pathway.
Sakata K; Kato S; Fox JC; Shigemori M; Morimatsu M
J Neuropathol Exp Neurol; 2002 Nov; 61(11):975-83. PubMed ID: 12430714
[TBL] [Abstract][Full Text] [Related]
31. Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells.
Ozasa A; Komatsu Y; Yasoda A; Miura M; Sakuma Y; Nakatsuru Y; Arai H; Itoh N; Nakao K
Bone; 2005 Jun; 36(6):1056-64. PubMed ID: 15869918
[TBL] [Abstract][Full Text] [Related]
32. Activin A stimulates the proliferation and differentiation of cardiac fibroblasts via the ERK1/2 and p38-MAPK pathways.
Hu J; Wang X; Wei SM; Tang YH; Zhou Q; Huang CX
Eur J Pharmacol; 2016 Oct; 789():319-327. PubMed ID: 27477354
[TBL] [Abstract][Full Text] [Related]
33. Cytosolic and calcium-independent phospholipase A(2) mediate glioma-enhanced proangiogenic activity of brain endothelial cells.
Giurdanella G; Motta C; Muriana S; Arena V; Anfuso CD; Lupo G; Alberghina M
Microvasc Res; 2011 Jan; 81(1):1-17. PubMed ID: 21094175
[TBL] [Abstract][Full Text] [Related]
34. Uncoupling of cell proliferation and differentiation activities of basic fibroblast growth factor.
Bailly K; Soulet F; Leroy D; Amalric F; Bouche G
FASEB J; 2000 Feb; 14(2):333-44. PubMed ID: 10657989
[TBL] [Abstract][Full Text] [Related]
35. Actions of fibroblast growth factor-8 in bone cells in vitro.
Lin JM; Callon KE; Lin JS; Watson M; Empson V; Tong PC; Grey A; Naot D; Green CR; Reid IR; Cornish J
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E142-50. PubMed ID: 19383871
[TBL] [Abstract][Full Text] [Related]
36. Fas-induced expression of chemokines in human glioma cells: involvement of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase.
Choi C; Xu X; Oh JW; Lee SJ; Gillespie GY; Park H; Jo H; Benveniste EN
Cancer Res; 2001 Apr; 61(7):3084-91. PubMed ID: 11306491
[TBL] [Abstract][Full Text] [Related]
37. Expression of the IIIc variant of FGF receptor-1 confers mitogenic responsiveness to heparin and FGF-5 in TAKA-1 pancreatic ductal cells.
Kornmann M; Lopez ME; Beger HG; Korc M
Int J Pancreatol; 2001; 29(2):85-92. PubMed ID: 11876253
[TBL] [Abstract][Full Text] [Related]
38. Glial cell-derived neurotrophic factor (GDNF) promotes low-grade Hs683 glioma cell migration through JNK, ERK-1/2 and p38 MAPK signaling pathways.
Song H; Moon A
Neurosci Res; 2006 Sep; 56(1):29-38. PubMed ID: 16814421
[TBL] [Abstract][Full Text] [Related]
39. P2Y(2) receptor-mediated proliferation of C(6) glioma cells via activation of Ras/Raf/MEK/MAPK pathway.
Tu MT; Luo SF; Wang CC; Chien CS; Chiu CT; Lin CC; Yang CM
Br J Pharmacol; 2000 Apr; 129(7):1481-9. PubMed ID: 10742305
[TBL] [Abstract][Full Text] [Related]
40. PDGF and FGF-2 signaling in oligodendrocyte progenitor cells: regulation of proliferation and differentiation by multiple intracellular signaling pathways.
Baron W; Metz B; Bansal R; Hoekstra D; de Vries H
Mol Cell Neurosci; 2000 Mar; 15(3):314-29. PubMed ID: 10736207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
